Two-in-one boron compound fights tumors and powers neutron capture therapy
A carborane-quinazoline hybrid derived from erlotinib delivered boron to tumor cells far more efficiently than BPA and delayed tumor growth ...
A carborane-quinazoline hybrid derived from erlotinib delivered boron to tumor cells far more efficiently than BPA and delayed tumor growth ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.